Keywords: Dompe, Anabasis, M&A, Nerve growth factor, Neurtropic keratitis

Dompe to acquire 100% control of Anabasis

Article | 01 March 2012

Italian biopharmaceutical firm Dompe has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in